A Dose-escalation Study of RO7567132 as Single Agent and in Combination With Atezolizumab in Participants With Advanced Solid Tumors
Clinical trial NCT06537310 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06537310
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-16
- Primary completion
- 2027-05-12
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.